RNA Therapeutics: The World’s First mRNA Malaria Vaccine

Malaria represents one of the greatest unmet clinical needs in the world. In the last decade, research has been ongoing to develop effective preventative methods and effective treatment to reduce the risk of severe illness, which typically occurs in children....

4 months ago
R&D,Biology

RNA Therapeutics: The World’s First mRNA Malaria Vaccine

Malaria represents one of the greatest unmet clinical needs in the world. In the last decade, research has been ongoing to develop effective preventative methods and effective treatment to reduce the risk of severe illness, which typically occurs in children....

4 months ago

Intrinsically Disordered Proteins – The Implication in Cancer and Potential Drug Targets

Intrinsically disordered proteins (IDPs) are under the limelight in cancer research. While research is continuous in understanding their dynamic structure, their implication in tumour development is becoming increasingly evident. Some of the latest advancements demonstrate how IDPs can be used...

4 months ago
Oncology,R&D

Intrinsically Disordered Proteins – The Implication in Cancer and Potential Drug Targets

Intrinsically disordered proteins (IDPs) are under the limelight in cancer research. While research is continuous in understanding their dynamic structure, their implication in tumour development is becoming increasingly evident. Some of the latest advancements demonstrate how IDPs can be used...

4 months ago

RNA Therapeutics: Innovations in Disease Research and Drug Development

RNA has proven in the last decade to be a valid therapeutic target for a multitude of diseases. The ability to manipulate the genetic code to produce almost any protein is one of the many advantages that has also led...

5 months ago
R&D,Biology

RNA Therapeutics: Innovations in Disease Research and Drug Development

RNA has proven in the last decade to be a valid therapeutic target for a multitude of diseases. The ability to manipulate the genetic code to produce almost any protein is one of the many advantages that has also led...

5 months ago

Emerging Innovations in Translational Medicine: An Interview with Marcie Glicksman, Enclear Therapies

3D cultures and organ-on-a-chip are a few examples of technologies that hope to bridge the gap from benchside to clinic. Failures that arise during drug development often arise due to poor translatability from models in preclinical studies to the patients...

5 months ago
R&D,Biology

Emerging Innovations in Translational Medicine: An Interview with Marcie Glicksman, Enclear Therapies

3D cultures and organ-on-a-chip are a few examples of technologies that hope to bridge the gap from benchside to clinic. Failures that arise during drug development often arise due to poor translatability from models in preclinical studies to the patients...

5 months ago

Drugs in Space: How Extraterrestrial Experiments Help Us Develop Medicine

Over the last 20 years, fundamental scientific research has been conducted by astronauts aboard the international space station (ISS). It has only been recently that the pharmaceutical and biotech sectors have invested in extraterrestrial experiments, hoping to find novel ways...

5 months ago
R&D,Biology

Drugs in Space: How Extraterrestrial Experiments Help Us Develop Medicine

Over the last 20 years, fundamental scientific research has been conducted by astronauts aboard the international space station (ISS). It has only been recently that the pharmaceutical and biotech sectors have invested in extraterrestrial experiments, hoping to find novel ways...

5 months ago

Vaccines and Variants: How Do They Work?

As of 23 June 2021, there are 14 variants of COVID-19 which are of concern or under investigation in the UK, according to the UK government. The unique profile of COVID-19 enables rapid mutation, producing variants which are more transmissible...

5 months ago
R&D,Biology,News

Vaccines and Variants: How Do They Work?

As of 23 June 2021, there are 14 variants of COVID-19 which are of concern or under investigation in the UK, according to the UK government. The unique profile of COVID-19 enables rapid mutation, producing variants which are more transmissible...

5 months ago

Building a FAIR Culture in Pharma

The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...

5 months ago
R&D,Bioinformatics,Data,News

Building a FAIR Culture in Pharma

The development of a ‘Findable, Accessible, Interoperable and Reusable’ (FAIR) data approach has been an exciting step towards an information-centric approach for the pharmaceutical industry. The potential benefits of this alternative approach to data management and accessibility could significantly support...

5 months ago

Utilising Machine Learning in Drug Discovery: Opportunities and Challenges

From artificial neural networks to predictive modelling, artificial intelligence (AI) is making its mark in the pharmaceutical industry. The ever-increasing cost of development, shorter timelines and rise in demand has seen the industry reach out to AI to help bring...

5 months ago
R&D,AI & ML,News

Utilising Machine Learning in Drug Discovery: Opportunities and Challenges

From artificial neural networks to predictive modelling, artificial intelligence (AI) is making its mark in the pharmaceutical industry. The ever-increasing cost of development, shorter timelines and rise in demand has seen the industry reach out to AI to help bring...

5 months ago

The Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu

Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...

6 months ago
R&D,Precision and Personalised Medicine,Biology,News

The Potential of Therapeutic Psychedelics Drugs: An Interview with Professor Albert Garcia-Romeu

Mental health conditions like addiction and diseases like Alzheimer’s represent a great unmet clinical need. Psychedelic research at preclinical stages have shown potential for positive neurological changes in the brain for models of depression, addiction and Alzheimer's. In a recent...

6 months ago

Strategies Implemented for New Modalities of Therapeutic Targeting: ASOs and RNAi

In 2018, the FDA approved the first small interfering RNA (siRNA) drug, patisiran, to treat a disease known as hereditary transthyretin amyloidosis. Since then, an increasing number of oligonucleotide-based drugs have reached the market, showing advantages over small molecule drugs....

6 months ago
R&D,Bioprocess,Biology,News

Strategies Implemented for New Modalities of Therapeutic Targeting: ASOs and RNAi

In 2018, the FDA approved the first small interfering RNA (siRNA) drug, patisiran, to treat a disease known as hereditary transthyretin amyloidosis. Since then, an increasing number of oligonucleotide-based drugs have reached the market, showing advantages over small molecule drugs....

6 months ago